Cardioprotective Drug Prevents Severe Cardiac Events in Children Undergoing Chemotherapy for Acute Myeloid Leukemia
Published on
CHOP researchers found the use of dexrazoxane throughout AML treatment had a significantly lower risk of developing cardiac complications.